Inspire Billing Codes Scheduled for 2028

Stock Titan reports that new billing codes for Inspire are scheduled for 2028. The publisher also reports that more than 140,000 patients have been treated for sleep apnea with Inspire.

Medicare payment values slated for 2027

According to Stock Titan, CMS will determine Medicare payment values for the new codes. Inspire expects proposed valuations in July 2027 and final valuations in November 2027.

The reported sequence places the Medicare payment-value process before the scheduled 2028 start for the new billing codes. For medical-device sales professionals working with sleep apnea treatment stakeholders, the update provides a defined reimbursement timeline to follow.

Billing-code timeline for Inspire

Stock Titan identifies three milestones in the reported coding and payment process. The first two concern expected Medicare payment valuations, while the third is the scheduled timing for the new billing codes.

• July 2027: Inspire expects proposed valuations.
• November 2027: Inspire expects final valuations.
• 2028: New billing codes are scheduled.

CMS will determine Medicare payment values for the new codes, Stock Titan reports. The publisher’s timeline distinguishes between proposed and final valuations, with both expected in 2027.

Sales relevance

For customer-facing medical-device professionals, the reported development centers on reimbursement coding and Medicare payment values for Inspire. Stock Titan’s account names CMS as the organization that will determine payment values and identifies the expected July and November 2027 valuation milestones.

The scheduled 2028 billing-code timing and the expected 2027 valuation process are the key details cited by Stock Titan. Professionals tracking sleep apnea treatment reimbursement can use those published milestones when following subsequent CMS payment-value determinations.